The reported statements, read against the company's own industry.
Financials view
Market Capitalization
683.89MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue (TTM)
2.83BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Beta
0.9630x
vs all stocks
Updated Jul 19, 2026
52-Week Change
-44.01%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
683.89MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
4.33BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Forward P/E
11.93x
Updated Jul 19, 2026
Price to Sales (TTM)
0.2417x
Updated Jul 19, 2026
Enterprise to Revenue
1.53x
Updated Jul 19, 2026
Enterprise to EBITDA
10.49x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 9.96×.Updated Jul 19, 2026
Gross Margin
32.87%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 56.54%.Updated Jul 19, 2026
Operating Margin
15.25%
Updated Jul 19, 2026
Return on Assets (TTM)
5.13%
Updated Jul 19, 2026
Revenue (TTM)
2.83BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
7.18USDUpdated Jul 19, 2026
Quarterly Revenue Growth
8.30%
Updated Jul 19, 2026
Gross Profit (TTM)
1.60BUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
435.09MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
-241.74MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
-77.00%
Updated Jul 19, 2026
Operating Cash Flow (TTM)
-185.05MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
143.04MUSD
vs all stocks (USD)
Updated Jul 19, 2026
5-Year Average Dividend Yield
2.98%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
Updated Jul 19, 2026
Minority Interest (Equity)
26.57MUSDFY2025 · Dec 31, 2025
Revenue
2.77BUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
1.92BUSDFY2025 · Dec 31, 2025
Gross Profit
852.90MUSDFY2025 · Dec 31, 2025
Operating Income
295.50MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-239.23MUSDFY2025 · Dec 31, 2025
Income Tax Expense
16.26MUSDFY2025 · Dec 31, 2025
Net Income
523.96MUSDFY2025 · Dec 31, 2025
EBIT
208.59MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
405.19MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
557.40MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
447.83MUSDFY2025 · Dec 31, 2025
EPS (Basic)
1.34USDFY2025 · Dec 31, 2025
EPS (Diluted)
1.34USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
391.71MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
391.71MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
523.96MUSDFY2025 · Dec 31, 2025
Minority Interests (P&L)
655.00KUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-215.09MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-297.98MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
910.11MUSDFY2025 · Dec 31, 2025
Interest Paid
589.04MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
523.96MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
105.92MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
5.13MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
45.66MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
-890.49MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-65.29MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
126.18MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-66.17MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-82.89MUSDFY2025 · Dec 31, 2025
Purchase of Investments
0.00USDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
9.07MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-73.82MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
3.22BUSDFY2025 · Dec 31, 2025
Long-term Debt Payments
-3.81BUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-86.46MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-675.34MUSDFY2025 · Dec 31, 2025
Shares Outstanding
395.31MSharesUpdated Jul 19, 2026
Float Shares
262.21MSharesUpdated Jul 19, 2026
Shares Short
35.68MSharesUpdated Jul 19, 2026
Short Ratio
5.82days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
12.73%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 9.03%.Updated Jul 19, 2026
% Held by Insiders
16.42%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
89.31%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
643.57MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
1.63USDUpdated Jul 19, 2026
Total Debt (MRQ)
4.27BUSD
vs all stocks (USD)
Updated Jul 19, 2026
Current Ratio (MRQ)
0.9250x
Updated Jul 19, 2026
Book Value per Share (MRQ)
-2.63USDUpdated Jul 19, 2026
Total Assets
4.50BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.30BUSDFY2025 · Dec 31, 2025
Total Liabilities
5.53BUSDFY2025 · Dec 31, 2025
Total Non-current Assets
3.21BUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
4.31BUSDFY2025 · Dec 31, 2025
Total Current Liabilities
1.21BUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
791.55MUSDFY2025 · Dec 31, 2025
Accounts Receivable
311.87MUSDFY2025 · Dec 31, 2025
Accounts Payable
260.04MUSDFY2025 · Dec 31, 2025
Short-term Debt
245.65MUSDFY2025 · Dec 31, 2025
Deferred Revenue
58.41MUSDFY2025 · Dec 31, 2025
Long-term Debt
4.15BUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
50.01MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
4.27MUSDFY2025 · Dec 31, 2025
Retained Earnings
-3.80BUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
-1.02BUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
537.20MUSDFY2025 · Dec 31, 2025
52-Week Low
0.8100USDUpdated Jul 19, 2026
52-Week High
3.29USDUpdated Jul 19, 2026
52-Week Change
-44.01%
vs all stocks
Updated Jul 19, 2026
Beta
0.9630x
vs all stocks
Updated Jul 19, 2026
50-Day MA
1.81USDUpdated Jul 19, 2026
200-Day MA
1.62USDUpdated Jul 19, 2026
Avg 10-Day Volume
3.36MSharesUpdated Jul 19, 2026
Avg 30-Day Volume
5.07MSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
-0.6200USDUpdated Jul 19, 2026
Other Income / Expense
-86.90MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Downstream position: depends on 18 industries, supplies 6Notable
Outgoing: 6.00Incoming: 18.00
High connectivity hub: 24 industry connectionsNotable
Total Connections: 24.00
Scale
Revenue is $2.83B, above the global median of $520.53MNotable